The χ2-test was applied to assess the relationship between the expressions of IFITM1 and the clinical and pathologic features of patients with pancreatic cancer, including gender, age at diagnosis, tumor size, histologic differentiation, TNM stage, nodal status, and distant metastasis. The gene discussed is IFITM1; the disease is pancreatic neoplasm.